Chapter 12: AI in Cellular and Enzyme Engineering
Synopsis
Author
Mr. Gourab Saha,
Associate Professor, Department of Pharmaceutics, College of Pharmaceutical Sciences, Berhampur, Mohada, Odisha, India
Abstract
The intersection of Artificial Intelligence and cell biology has birthed the field of quantitative systems cytology, where deep learning automates the interpretation of complex cellular imagery, moving beyond subjective manual observation. This section explores the application of Convolutional Neural Networks (CNNs) in bioimage analysis, detailing how these architectures perform pixel-perfect segmentation to identify, outline, and classify subcellular organelles within high-content microscopy data. These automated systems transcend human visual limitations, quantifying subtle phenotypic changes and morphological descriptors in real-time to accelerate high-throughput drug screening and precision medical diagnostics. Parallel to this visual revolution, machine learning transforms the field of enzyme engineering by rationalizing the optimization of biocatalysts for industrial applications. Algorithms replace traditional trial-and-error methods, such as one-factor-at-a-time optimization, in enzyme immobilization. They utilize Design of Experiments principles to predict the precise physicochemical conditions such as pH, temperature, and support matrix composition required to maximize operational stability and catalytic efficiency. Additionally, AI-guided directed evolution explores the vast protein fitness region to design novel enzyme variants with enhanced solvent tolerance and activity. This shows how computational intelligence bridges the gap between understanding cellular architecture and engineering robust biological tools, facilitating the development of efficient bioprocesses and advanced diagnostic platforms.
Keywords: Bioimage Analysis, U-Net Architecture, Enzyme Immobilization, Directed Evolution (MLDE), High-Content Screening, Design of Experiments (DoE)
. 